Sandu Pharmaceuticals Ltd — Important, 07-05-2026: Company Update

Sandu Pharmaceuticals has published its financial results for the quarter and year ended March 31. For the latest quarter, total income from operations was 17.22 Cr, with a net profit of 0.04 Cr. Annual results show total income from operations at 70.38 Cr and a net profit of 1.77 Cr. The company's equity share capital stood at 9.66 Cr, and reserves were 25.59 Cr. These audited results, indicating the company's financial health, were approved by the Board.